DeepMed Research

FRED HUTCHINSON CANCER CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Employees: -

Market Cap: -

Website: https://www.fredhutch.org

Clinical Trials

Identifying Best Approach in Improving Quality of Life and Survival After a Donor Stem Cell Transplant in Older, Medically Infirm, or Frail Patients With Blood Diseases

Phase 2

Active, not recruiting

Conditions: Hematopoietic and Lymphoid Cell Neoplasm
Non-Neoplastic Hematologic and Lymphocytic Disorder

Interventions: Other: Clinical Management
Other: Supportive Palliative Care
Other: Best Practice
Procedure: Allogeneic Hematopoietic Stem Cell Transplantation
Other: Questionnaire Administration
Other: Quality-of-Life Assessment
Other: Survey Administration

First Posted Date: 2019-03-12

Last Posted Date: 2024-12-31

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 455

Registration Number: NCT03870750

Locations: 🇺🇸
Northwell Health Cancer Institute, New Hyde Park, New York, United States
🇺🇸
Stanford Cancer Institute Palo Alto, Palo Alto, California, United States
🇺🇸
University of California San Francisco, San Francisco, California, United States

and more 8 locations

Rituximab Hyaluronidase in Combination With Chemotherapy in Treating Aggressive B-cell Lymphoma in Uganda

Phase 1

Terminated

Conditions: Diffuse Large B-Cell Lymphoma
Burkitt Lymphoma
KSHV-associated Multicentric Castleman Disease

Interventions: Biological: Rituximab and Hyaluronidase Human
Drug: Cyclophosphamide
Drug: Vincristine
Drug: Methotrexate
Drug: Doxorubicin
Biological: Rituximab
Drug: Doxorubicin Hydrochloride
Drug: Prednisone
Drug: Etoposide

First Posted Date: 2019-03-06

Last Posted Date: 2024-01-03

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 18

Registration Number: NCT03864419

Locations: 🇺🇬
UCI-Fred Hutch Cancer Centre, Kampala, Uganda

Glucosamine and Chondroitin in Preventing Inflammation in Overweight Patients

Phase 1

Completed

Conditions: Healthy Subject
Overweight

Interventions: Dietary Supplement: Glucosamine
Other: Placebo

First Posted Date: 2019-02-01

Last Posted Date: 2019-02-01

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 2

Registration Number: NCT03827161

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Rivogenlecleucel Donor Lymphocyte Immunotherapy in Treating Patients With Recurrent Blood Cancers After Stem Cell Transplant

Phase 1

Withdrawn

Conditions: Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
Recurrent Acute Myeloid Leukemia
Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive
Myeloproliferative Neoplasm
Recurrent Acute Lymphoblastic Leukemia
Recurrent Chronic Lymphocytic Leukemia
Recurrent Myelodysplastic Syndrome
Acute Bilineal Leukemia
Myelodysplastic/Myeloproliferative Neoplasm
Recurrent Acute Biphenotypic Leukemia

Interventions: Biological: Rivogenlecleucel
Drug: Rimiducid

First Posted Date: 2019-01-16

Last Posted Date: 2020-08-14

Lead Sponsor: Fred Hutchinson Cancer Center

Registration Number: NCT03807063

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Reducing Insulin, Growth Hormones, and Tumors

Not Applicable

Terminated

Conditions: Diet Modification
Lung Cancer

Interventions: Behavioral: Special Diet Therapy (low-carb)
Behavioral: Special Diet Therapy (low-fat)
Behavioral: Special Diet Therapy (USDA control)

First Posted Date: 2018-12-24

Last Posted Date: 2019-08-12

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 3

Registration Number: NCT03785808

Locations: 🇺🇸
Seattle Cancer Center Alliance, Seattle, Washington, United States

Pilot Trial of Resistant Starch in Stage I-III Colorectal Cancer Survivors

Phase 2

Terminated

Conditions: Stage IIIC Colorectal Cancer AJCC v8
Rectal Cancer
Stage IIB Colorectal Cancer AJCC v8
Stage IIIB Colorectal Cancer AJCC v8
Colon Cancer
Cancer Survivor
Colorectal Adenocarcinoma
Stage I Colorectal Cancer AJCC v8
Stage II Colorectal Cancer AJCC v8
Stage IIA Colorectal Cancer AJCC v8

Interventions: Other: Dietary Intervention (resistant starch)
Other: Dietary Intervention (regular starch)
Other: Questionnaire Administration

First Posted Date: 2018-12-20

Last Posted Date: 2022-10-06

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 10

Registration Number: NCT03781778

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant

Phase 2

Recruiting

Conditions: Acute Biphenotypic Leukemia
Acute Leukemia
Acute Leukemia of Ambiguous Lineage
Acute Lymphoblastic Leukemia
Acute Undifferentiated Leukemia
Allogeneic Hematopoietic Stem Cell Transplantation Recipient
Blastic Plasmacytoid Dendritic Cell Neoplasm
Blasts Under 25 Percent of Bone Marrow Nucleated Cells
Blasts Under 5 Percent of Bone Marrow Nucleated Cells
Mixed Phenotype Acute Leukemia

Interventions: Radiation: Total-Body Irradiation
Drug: Thiotepa
Drug: Fludarabine
Drug: Cyclophosphamide
Drug: Busulfan
Drug: Tacrolimus
Procedure: Allogeneic Bone Marrow Transplantation
Drug: Methotrexate
Procedure: Naive T Cell-Depleted Hematopoietic Stem Cell Transplantation
Procedure: Echocardiography
Procedure: Biospecimen Collection
Procedure: Bone Marrow Aspiration
Procedure: Bone Marrow Biopsy

First Posted Date: 2018-12-19

Last Posted Date: 2025-04-23

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 68

Registration Number: NCT03779854

Locations: 🇺🇸
Children's Hospital of Los Angeles, Los Angeles, California, United States
🇺🇸
Children's National Medical Center, Washington, District of Columbia, United States
🇺🇸
Children's Healthcare of Atlanta, Atlanta, Georgia, United States

and more 7 locations

Acute Exercise Intervention in Breast Cancer Survivors

Not Applicable

Terminated

Conditions: Breast Carcinoma

Interventions: Other: Resting
Behavioral: Exercise Intervention
Other: Biomarker Analysis
Other: Questionnaire Administration

First Posted Date: 2018-12-19

Last Posted Date: 2025-01-23

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 112

Registration Number: NCT03779867

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Yeego! Healthy Eating & Gardening School-Based Randomized Controlled Trial

Not Applicable

Completed

Conditions: Health Behavior
Dietary Habits
Eating Behavior

Interventions: Behavioral: Behavioral Gardening Exposure
Behavioral: Healthy Eating and Gardening Curriculum

First Posted Date: 2018-12-19

Last Posted Date: 2022-12-23

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 294

Registration Number: NCT03778021

Locations: 🇺🇸
Agricultural Science Center at Farmington, College of Agricultural, Consumer, and Environmental Sciences, New Mexico State University, Farmington, New Mexico, United States
🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Engaging School and Family in Navajo Gardening for Health

Not Applicable

Completed

Conditions: Dietary Habits
Eating Behavior
Health Behavior

Interventions: Behavioral: Gardening

First Posted Date: 2018-12-14

Last Posted Date: 2019-04-16

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 40

Registration Number: NCT03775889

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy